Profiling crystal engineered ligands for targeting treatment resistant androgen receptors
Avan N Colah, Charles Izuchukwu Ezekiel, Sára Ferková, Pierre‐Luc Boudreault, Leonard Richard MacGillivray, William A. Ricke
This study develops and evaluates crystal-engineered ligands (CBs) for targeting treatment-resistant androgen receptors in prostate cancer, showing their potential as novel therapeutic agents.
Frontiers in Pharmacology · Sep 28, 2026Peer-reviewedMolecular Biology